TransMedics Group, Inc. (TMDX) Presents at Morgan Stanley 23rd Annual Global Healthcare

[ad_1]

TransMedics Group, Inc. (NASDAQ:TMDX) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 10:00 AM EDT

Company Participants

Waleed Hassanein – Founder, President, CEO & Director
Gerardo Hernandez – CFO & Treasurer

Conference Call Participants

Patrick Wood – Morgan Stanley, Research Division

Presentation

Patrick Wood
MD of Equity Research

Hi, everybody. Welcome and thanks for joining. Welcome to the — I guess, the first day of the Morgan Stanley Global Healthcare Conference. So very excitedly, for important disclosures, morganstanley.com/researchdisclosures. So yes, that’s very exciting. And very excited today to have TransMedics, we’ve got Waleed, who’s the Founder and CEO; and Gerardo, who’s the CFO here. And so I really appreciate the time. Thanks for coming guys.

Waleed Hassanein
Founder, President, CEO & Director

Thank you, Patrick.

Gerardo Hernandez
CFO & Treasurer

Thank you.

Patrick Wood
MD of Equity Research

We were just saying how thematically appropriate having Staying Alive on the soundtrack was for an organ transplant company. So it kind of works well.

Question-and-Answer Session

Patrick Wood
Morgan Stanley, Research Division

I guess — so maybe starting kind of big picture. It’s been a strong year. There’s a lot on the pipeline. Sitting here today and you had that original target of 10,000 organs. And how are you feeling about 1,000-foot view, the world and where the business is today, just big picture?

Waleed Hassanein
Founder, President, CEO & Director

We feel great. We — as Gerardo said, a few weeks back, we are already past the 10,000 target internally. We’re already setting our eyes at 20,000, 30,000 transplants by 2030. Yes, we feel great, and we’re looking forward to just continuing to execute.

Patrick Wood
Morgan Stanley, Research Division

If you think of the journey that you guys have been on getting to where you are now, is anything that sort

[ad_2]